August 2, 2021
2 mins read

India, UK to conduct clinical trials of Ashwagandha

Ashwagandha (Withania Somnifera), commonly known as ‘Indian winter cherry’, is a traditional Indian herb that boosts energy, reduces stress, and makes the immune system stronger…reports Asian Lite News.

The Ayush ministry’s All India Institute of Ayurveda in collaboration with the United Kingdom’s London School of Hygiene and Tropical Medicine will conduct a study on ‘Ashwagandha’ for promoting recovery from Covid-19 in a boost to the traditional Indian medicine system.

Both the institutions signed a Memorandum of Understanding to conduct the clinical trials of Ashwagandha on 2,000 people in three UK cities — Leicester, Birmingham, and London (Southall and Wembley), said the ministry in a statement.

Ashwagandha (Withania Somnifera), commonly known as ‘Indian winter cherry’, is a traditional Indian herb that boosts energy, reduces stress, and makes the immune system stronger.

It is an easily accessible, over-the-counter nutritional supplement in the UK and has a proven safety profile. The positive effects of Ashwagandha have been observed in Covid, which is a multi-system disease with no evidence of its effective treatment or management.

The successful completion of the trial can be a major breakthrough and give scientific validity to India’s traditional medicinal system. While there have been several studies on Ashwagandha to understand its benefits in various ailments, this is the first time the Ministry has collaborated with a foreign institution to investigate its efficacy on Covid-19 patients.

AIIA director Dr Tanuja Manoj Nesari, who is also a co-investigator in the project along with Dr Rajgopalan, Coordinator – International Projects, said that the participants have been randomly selected. Dr Sanjay Kinra of LSHTM is the principal investigator of the study.

The participants will have to take the 500mg tablets twice a day. A monthly follow-up of self-reported quality of life, impairment to activities of daily living, mental and physical health symptoms, supplement use and adverse events will be carried out.

“For three months, one group of 1,000 participants will be administered Ashwagandha (AG) tablets while the second group of 1,000 participants will be assigned a placebo, which is indistinguishable from AG in looks and taste. Both patients and the doctors will be unaware of the group’s treatment in a double-blind trial,” Dr Nesari said.

ALSO READ-World Hindu Economic Forum hosts Webinar on Ayurveda

READ MORE-Verstegen, Sri Sri Tattva join hands to offer sustainable agri solutions in Europe, UK

Previous Story

UK reports 24,470 Covid-19 cases, 65 deaths

Next Story

UK offers discounts on shopping, pizza for Covid shots

Latest from -Top News

Dhaka’s Ruling Party Rejects Kolkata Link

Slamming the Yunus administration, the Awami League alleged that “the illegal usurper government is actively spreading these baseless rumours….reports Asian Lite News Bangladesh’s Awami League has rejected media reports that it opened

1.5M Afghans Forced Back in 2025

UN warned that these women and girls face significant threats upon their return to Afghanistan, including poverty, early marriage, violence, and unprecedented restrictions. The International Organization for Migration (IOM) has warned that

How BRICS Break the West’s Grip

Harvansh Chawla pointed to the Ruble-Rupee trade arrangement between the two nations, saying it has streamlined transactions and lessened reliance on Western financial systems. The BRICS bloc is proving crucial in enabling

Greece may extend North Africa asylum ban

In July, the government stopped processing asylum requests from migrants arriving from North Africa by sea for three months in an effort to curb arrivals from Libya to Crete Plevris said he

EU Demands Seat in US–Russia Ceasefire Talks

Kallas revealed that she would convene an online meeting of EU foreign ministers on Monday to discuss “our next steps EU foreign policy chief Kaja Kallas said any US–Russia agreement must involve
Go toTop

Don't Miss

‘US help for Ukraine is not too late’

The necessary Senate approval is considered certain and is expected

Sitharaman, Gopinath discuss downside risks to economy

The meeting took place on Tuesday on the sidelines of